Dopamine and noradrenergic reuptake inhibitors in treatment of schizophrenia
Patent 5447948 Issued on September 5, 1995. Estimated Expiration Date: 
September 5, 2012. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
September 5, 2012. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesMethod and pharmaceutical composition for the treatment of schizophrenia Phenoxyphenyl derivatives, compositions and methods of use thereof Patent #: 5190965 InventorsApplicationNo. 880127 filed on 05/07/1992US Classes:514/393, Polycyclo ring system having the diazole ring as one of the cyclos514/327Chalcogen bonded directly to ring carbon of the piperidine ringExaminersPrimary: Henley, III, RaymondAssistant: Jarvis, William R. A. Attorney, Agent or FirmInternational ClassesA61K 031/415A61K 031/445 AbstractMazindol and other dopamine and/or noradrenergic reuptake inhibitors are effective to treat negative symptoms in schizophrenia.Other References
| |
